162 related articles for article (PubMed ID: 35615349)
1. Pharmacological Inhibition of MALT1 Ameliorates Autoimmune Pathogenesis and Can Be Uncoupled From Effects on Regulatory T-Cells.
Biswas S; Chalishazar A; Helou Y; DiSpirito J; DeChristopher B; Chatterjee D; Merselis L; Vincent B; Monroe JG; Rabah D; Long AJ
Front Immunol; 2022; 13():875320. PubMed ID: 35615349
[TBL] [Abstract][Full Text] [Related]
2. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.
Martin K; Junker U; Tritto E; Sutter E; Rubic-Schneider T; Morgan H; Niwa S; Li J; Schlapbach A; Walker D; Bigaud M; Beerli C; Littlewood-Evans A; Rudolph B; Laisney M; Ledieu D; Beltz K; Quancard J; Bornancin F; Zamurovic Ribrioux N; Calzascia T
Front Immunol; 2020; 11():745. PubMed ID: 32425939
[TBL] [Abstract][Full Text] [Related]
4. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
Front Immunol; 2019; 10():1898. PubMed ID: 31474984
[TBL] [Abstract][Full Text] [Related]
5. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
7. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
[TBL] [Abstract][Full Text] [Related]
8. A patent review of MALT1 inhibitors (2013-present).
Hamp I; O'Neill TJ; Plettenburg O; Krappmann D
Expert Opin Ther Pat; 2021 Dec; 31(12):1079-1096. PubMed ID: 34214002
[TBL] [Abstract][Full Text] [Related]
9. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
Baens M; Stirparo R; Lampi Y; Verbeke D; Vandepoel R; Cools J; Marynen P; de Bock CE; Bornschein S
Eur J Immunol; 2018 Oct; 48(10):1728-1738. PubMed ID: 30025160
[TBL] [Abstract][Full Text] [Related]
10. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
[TBL] [Abstract][Full Text] [Related]
12. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
Afonina IS; Elton L; Carpentier I; Beyaert R
FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.
Kip E; Staal J; Tima HG; Verstrepen L; Romano M; Lemeire K; Suin V; Hamouda A; Baens M; Libert C; Kalai M; Van Gucht S; Beyaert R
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158289
[TBL] [Abstract][Full Text] [Related]
14. MALT1 protease function in regulatory T cells induces MYC activity to promote mitochondrial function and cellular expansion.
Rosenbaum M; Schnalzger T; Engleitner T; Weiß C; Mishra R; Mibus C; Mitterer T; Rad R; Ruland J
Eur J Immunol; 2022 Jan; 52(1):85-95. PubMed ID: 34668583
[TBL] [Abstract][Full Text] [Related]
15. MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial Cells.
Alfano DN; Klei LR; Klei HB; Trotta M; Gough PJ; Foley KP; Bertin J; Sumpter TL; Lucas PC; McAllister-Lucas LM
J Immunol; 2020 May; 204(9):2337-2348. PubMed ID: 32213560
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
Front Immunol; 2020; 11():576651. PubMed ID: 33042160
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis.
Gilis E; Gaublomme D; Staal J; Venken K; Dhaenens M; Lambrecht S; Coudenys J; Decruy T; Schryvers N; Driege Y; Dumas E; Demeyer A; De Muynck A; van Hengel J; Van Hoorebeke L; Deforce D; Beyaert R; Elewaut D
Arthritis Rheumatol; 2019 Dec; 71(12):2005-2015. PubMed ID: 31259485
[TBL] [Abstract][Full Text] [Related]
18. MALT1 is an intrinsic regulator of regulatory T cells.
Brüstle A; Brenner D; Knobbe-Thomsen CB; Cox M; Lang PA; Lang KS; Mak TW
Cell Death Differ; 2017 Jul; 24(7):1214-1223. PubMed ID: 26405015
[TBL] [Abstract][Full Text] [Related]
19. Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity.
Cheng L; Deng N; Yang N; Zhao X; Lin X
J Immunol; 2019 May; 202(10):3008-3019. PubMed ID: 30979818
[TBL] [Abstract][Full Text] [Related]
20. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
Bardet M; Unterreiner A; Malinverni C; Lafossas F; Vedrine C; Boesch D; Kolb Y; Kaiser D; Glück A; Schneider MA; Katopodis A; Renatus M; Simic O; Schlapbach A; Quancard J; Régnier CH; Bold G; Pissot-Soldermann C; Carballido JM; Kovarik J; Calzascia T; Bornancin F
Immunol Cell Biol; 2018 Jan; 96(1):81-99. PubMed ID: 29359407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
